| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |